Wellbeing Digital Sciences Inc. is an evidence-based mental healthcare company focused on the development and implementation of innovative clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. Its mission is supported by a network of North American clinics that provide forward-thinking therapies and other types of treatment to patients as well as through a contract research organization that offers clinical trials services to clients pursuing drug development.

Previously named Ketamine One Capital Limited; formerly Myconic Capital Corp.

Name Wellbeing Digital Services
Symbol MEDI
Website https://www.wellbeingdigital.co
Twitter https://twitter.com/ketamineone